TURKOZ, Y. Et Al. 2004. Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy. MEDIATORS OF INFLAMMATION , vol.13, no.2 , 127-130.

TURKOZ, Y., ER, H., BORAZAN, M., YILMAZ, H., MIZRAK, B., Parlakpinar, H., ... CIGREMIS, Y.(2004). Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy. MEDIATORS OF INFLAMMATION , vol.13, no.2, 127-130.

TURKOZ, YUSUF Et Al. "Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy," MEDIATORS OF INFLAMMATION , vol.13, no.2, 127-130, 2004

TURKOZ, YUSUF Et Al. "Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy." MEDIATORS OF INFLAMMATION , vol.13, no.2, pp.127-130, 2004

TURKOZ, Y. Et Al. (2004) . "Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy." MEDIATORS OF INFLAMMATION , vol.13, no.2, pp.127-130.

@article{article, author={YUSUF TÜRKÖZ Et Al. }, title={Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy}, journal={MEDIATORS OF INFLAMMATION}, year=2004, pages={127-130} }